Chimeric antigen receptor T cells (CAR T cells) therapy is one kind of immunotherapy that has revolutionally changed the landscape of immunotherapy and been approved by the FDA from 2017 for several blood malignancies. To bring new CAR T cells to clinic, every new CAR need to test in vitro for antigen recognition, tumor cell killing capacity, and off-target cytotoxicity effect. Detecting the secretion of cytokines upon engagement of CAR T cells with tumor antigens is routinely applied to assess these CAR functions. Here we describe coupling of intracellular cytokine staining and multicolor flow cytometry to measure CAR T cells activation upon antigen stimulation.
CITATION STYLE
Xu, C., & Yin, Y. (2020). Measuring chimeric antigen receptor T cells (CAR T Cells) activation by coupling intracellular cytokine staining with flow cytometry. In Methods in Molecular Biology (Vol. 2108, pp. 159–165). Humana Press Inc. https://doi.org/10.1007/978-1-0716-0247-8_14
Mendeley helps you to discover research relevant for your work.